Am J Transplant, Volume 20, Suppl 3 Archives - Page 80 of 223 - ATC Abstracts

2020 American Transplant Congress
Tacrolimus Concentrations Are Associated with Measures of Body Composition in Adult Kidney Transplant Recipients
K. S. Parker¹, B. Derstine², J. Sullivan², S. Wang², A. Mazurek¹, D. Cron¹, S. Waits¹
¹Department of Surgery, University of Michigan, Ann Arbor, MI, ²Morphomic Analysis Group, University of Michigan, Ann Arbor, MI
*Purpose: Tacrolimus (Tacro) is essential for kidney transplant immunosuppression but has a narrow therapeutic window. Tacro dosing preventing rejection must be balanced with potential delayed…
2020 American Transplant Congress
Post-Transplant Renal Function in ACLF Patients Based on Pre-Transplant Severity of Renal Dysfunction without Kidney Transplant
M. Yazawa¹, B. Maliakkal¹, S. Nair¹, Y. Jiang², P. S. Podila³, U. A. Agbim¹, S. Karri⁴, S. D. Khan⁵, D. Maluf¹, J. D. Eason¹, M. Z. Molnar¹, S. K. Satapathy⁶
¹James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, ²Division of Epidemiology, Biostatistics, and Environmental Health, The University of Memphis, Memphis, TN, ³Faith & Health Division, Methodist Le Bonheur Healthcare, Memphis, TN, ⁴Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, ⁵Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, ⁶Sandra Atlas Bass Center for Liver Diseases & Transplantation, Department of Medicine, Northshore University Hospital/Northwell Health, Manhasset, NY
*Purpose: It is unknown whether severity of renal dysfunction in ACLF patients impacts outcome of ACLF patients compared to those without ACLF.*Methods: In a single…
2020 American Transplant Congress
Steatosis by PDFF Affects Percent Remnant Liver Regeneration in Living Donors without Impacting on Clinical Outcomes
A. Duarte-Rojo, Q. Qi, K. Chupetlovska, D. R. Jorgensen, A. A. Borhani, A. Furlan, S. Ganesh, A. Humar
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Mild steatosis (5-33% of fat) is not expected to affect liver regeneration following partial hepatectomy. Novel methods to assess steatosis, such as proton density…
2020 American Transplant Congress
Pediatric Liver Post-Transplant Length of Stay Index
T. Zhang¹, S. Barrett¹, R. Cotton², T. Galvan², J. Vierling², C. O'Mahony², J. Goss², A. Rana²
¹Medical Student, Baylor College of Medicine, Houston, TX, ²Baylor College of Medicine, Houston, TX
*Purpose: PELD scores are used to reduce waitlist mortality, but they do not accurately predict likelihood of prolonged length of stay or higher costs associated…
2020 American Transplant Congress
Absolute Lymphocyte Count: Is There a “Safety Corridor?”
G. Elhelou¹, B. Lahr², R. Razonable³
¹Medicine, Division of Infectious Diseases and Global Medicine, University of Florida, Gainesville, FL, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ³Medicine, Division of Infectious Disease, Mayo Clinic, Rochester, MN
*Purpose: Iatrogenic suppression of T cells is intended to prevent rejection after solid organ transplantation (SOT). This is complicated by opportunistic infections, most notably cytomegalovirus…
2020 American Transplant Congress
Association between Ezetimibe Usage and Hepatitis C RNA Levels in Uninfected Kidney Transplant Recipients Who Received Hepatitis C Infected Kidneys
A. Azhar, M. Yazawa, M. Talwar, V. Balaraman, A. Bhalla, U. A. Agbim, B. Maliakkal, J. P. Kothadia, S. Nair, J. D. Eason, M. Z. Molnar
James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN
*Purpose: Our previous data showed that transplantation of kidneys from hepatitis C virus (HCV) infected donors to HCV negative recipients achieved excellent short-term graft function,…
2020 American Transplant Congress
Implicit Bias in Recipient Selection
Y. Sweidan¹, C. Mayuga¹, B. Daly¹, K. Chavin², T. Srinivas¹, A. Padiyar¹
¹Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, ²Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: The decision to place or exclude a candidate from the waitlist is not exclusively based on medical criteria. Scant literature exists regarding the intergroup…
2020 American Transplant Congress
Outreach as a Way to Improve Access to Kidney Transplants: A Model to Align with Future of Kidney Disease Care
A. Govil¹, P. Gudsoorkar¹, C. Siemer², C. King², T. Diwan¹, E. Woodle¹, S. Shah¹, C. V. Thakar¹
¹Univ of Cincinnati, Cincinnati, OH, ²UC Health, Cincinnati, OH
*Purpose: In 2018, there were more than 100,000 patients wait-listed for kidney transplant whereas only around 21,000 patients received a kidney transplant. Increasing access to…
2020 American Transplant Congress
Immune-Mediated Injury and Eplet Mismatches – Profiling Population-Level Interactions
H. Mohammadhassanzadeh¹, W. Zhang², W. Klement³, H. Gebel⁴, P. Keown⁵, K. Oualkacha⁶, R. Sapir-Pichhadze¹
¹Medicine, McGill University, Montreal, QC, Canada, ²McGill University, Montreal, QC, Canada, ³Organ Donation and Transplantation, Canadian Blood Services, Ottawa, ON, Canada, ⁴Emory University Hospital, Atlanta, GA, ⁵Medicine, University of British Columbia, Vancouver, BC, Canada, ⁶Université du Québec À Montréal, Montreal, QC, Canada
*Purpose: HLA genes are in linkage disequilibrium with each other. Sequence defined HLA targets (eplets) are associated with alleles and may be shared within and…
2020 American Transplant Congress
Taking it to the Max: Extremely Low LDL May Provide Benefit for Prevention of Cardiac Allograft Vasculopathy
R. Lee¹, E. J. Henricksen¹, Y. Moayedi², K. Y. Feng³, J. Han³, W. Yang⁴, R. Imai¹, J. J. Teuteberg⁴, K. K. Khush⁴
¹Pharmacy, Stanford Health Care, Stanford, CA, ²University Health Network, Toronto, ON, Canada, ³Medicine, Stanford University, Stanford, CA, ⁴Cardiac Transplant, Stanford University, Stanford, CA
*Purpose: Routine use of statins is the only Class I ISHLT recommendation in heart transplantation (HT) to reduce cardiac allograft vasculopathy (CAV) and improve survival.…